Metabolic and hemodynamic response of adipose tissue to angiotensin II

Obesity Research

Volumn 9, Issue 8, 2001, Pages 486-491

  Boschmann, Michael ^a   Ringel, Jens ^b   Klaus, Susanne ^a   Sharma, Arya M ^b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Blood flow; Glycolysis; Lipolysis; Metabolism; Microdialysis

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN II; ISOPRENALINE;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; ENERGY METABOLISM; HISTOLOGY; HUMAN; LIPOLYSIS; MALE; METABOLISM; METHODOLOGY; MICRODIALYSIS; PERFUSION; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULARIZATION;

ADIPOSE TISSUE; ADULT; ANGIOTENSIN II; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; HUMANS; ISOPROTERENOL; LIPOLYSIS; MALE; MICRODIALYSIS; PERFUSION; REGIONAL BLOOD FLOW; RENIN-ANGIOTENSIN SYSTEM; SYMPATHOMIMETICS;

EID: 0035430349     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2001.63     Document Type: Article

References (25)

1. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145-58.
2. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension, 2000;35:1270-7.
3. Peach MJ. Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev. 1977;57:313-70.
4. Timmermans PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-51.
5. Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Lancet. 1999;353:611-6.
6. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-53.
7. Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res. 1993;34:1057-91.
8. Lönnroth P, Smith U. Microdialysis - a novel technique for clinical investigations. J Intern Med. 1990;227:295-300.
9. Arner P. Techniques for the measurement of white adipose tissue metabolism: a practical guide. Int J Obes Relat Metab Disord. 1995;19:435-42.
10. Bernt E, Gutmann I. Ethanol determination with alcohol dehydrogenase and NAD. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Vol. 3. Weinheim, Germany: Verlag Chemie; 1974, pp. 1499-1505.
11. Lundin A, Arner P, Hellmér J. A new linear plot for standard curves in kinetic substrate assays extended above the Michaelis-Menten constant: application to a luminometric assay of glycerol. Anal Biochem. 1989;177:125-31.
12. Hellmér J, Arner P, Lundin A. Automated luminometric assay of glycerol for lipolysis studies. Anal Biochem. 1989; 177:132-7.
13. Enoksson S, Nordenstrom J, Bolinder J, Arner P. Influence of local blood flow on glycerol levels in human adipose tissue. Int J Obes Relat Metab Disord. 1995;19:350-4.
14. Fellander G, Linde B, Bounder L. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Rel Metab Disord. 1996;20:220-6.
15. Steinberg D, Vaughan M, Margolis S. Studies of triacylglyceride-biosynthesis in homogenates of adipose tissue. J Biol Chem. 1961;236:1631-7.
16. Arner P, Liljeqvist L, Östman J. Metabolism of mono-and diacyl-glycerols in subcutaneous adipose tissue of obese and normal weight subjects. Acta Med Scand. 1976;200:187-94.
17. Stahle L, Segersvard S, Ungerstedt U. A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J Pharmacol Methods. 1991;25:41-52.
18. Jones BH, Standridge MK, Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology. 1997;138:1512-9.
19. Leibel RL, Edens NK, Fried SK. Physiologic basis for the control of body fat distribution. Ann Rev Nutr. 1989;9: 417-43.
20. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissue. Ann Med. 1995;27:435-8.
21. English V, Cassis L. Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J Neural Transm. 1999;106:631-44.
22. Lönnroth P, Smith U. Intermediary metabolism with an emphasis on lipid metabolism, adipose tissue, and fat cell metabolism: a review. In: Björntorp P, Brodoff, BN. Obesity. Philadelphia, PA: JB Lippincott Company; 1992, pp. 3-14.
23. Darimont C, Vassaux G, Gaillard D, Ailhaud G, Negrel R. In situ microdialysis of prostaglandins in adipose tissue: stimulation of prostacyclin release by angiotensin II. Int J Obes Relat Metab Disord. 1994;18:783-8.
24. Nussberger J, Brunner DB, Waeber B, Brunner HR. Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. Hypertension. 1986;8: 476-82.
25. Campbell DJ, Kladis A. Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man. J Hypertens. 1990;8:165-72.